Long-term survival in patients treated with cardiac resynchronization therapy: A 3-year follow-up study from the InSync/InSync ICD Italian registry

PACE - Pacing and Clinical Electrophysiology

Volumn 29, Issue SUPPL. 2, 2006, Pages

  Gasparini, Maurizio ^a   Lunati, Maurizio ^b   Santini, Massimo ^c   Tritto, Massimo ^d   Curnis, Antonio ^e   Bocchiardo, Mario ^f   Vincenti, Antonio ^g   Pistis, Gianfranco ^h   Valsecchi, Sergio ⁱ   Denaro, Alessandra ⁱ  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c SAN FILIPPO NERI HOSPITAL   (Italy)

^d Mater Domini Hospital   (Italy)

^e SPEDALI CIVILI   (Italy)

^f Civil Hospital   (Italy)

^g SAN GERARDO HOSPITAL   (Italy)

^h MAURIZIANO HOSPITAL   (Italy)

ⁱ Medtronic Italia   (Italy)

Author keywords

Cardiac resynchronization therapy; Heart failure; Mortality

Indexed keywords

ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL EXAMINATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE ISCHEMIA; HUMAN; IMPLANT REGISTRY; ITALY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREDICTION; QRS COMPLEX; SURVIVAL; TEACHING HOSPITAL; TELEPHONE; UNIVERSITY HOSPITAL;

AGED; CARDIAC PACING, ARTIFICIAL; COMORBIDITY; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; ITALY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREVALENCE; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33751357372     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2006.00485.x     Document Type: Article

References (32)

1. Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001; 344:873-880.
2. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346:1845-1853.
3. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350:2140-2150.
4. Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352:1539-1549.
5. Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: Executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26:1115-1140.
6. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Circulation 2005; 112: 1116-1143.
7. Pappone C, Vicedomini G, Augello G, et al. Combining electrical therapies for advanced heart failure: The Milan experience with biventricular pacing - Defibrillation backup combination for primary prevention of sudden cardiac death. Am J Cardiol 2003; 91(Suppl.):74F-80F.
8. Hinkle LE, Thaler HT. Clinical classification of cardiac deaths. Circulation 1982; 65:457-464.
9. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantification of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989; 2:358-367.
10. Sahn DJ, DeMaria A, Kisslo J, et al. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 1978; 58:1072-1083.
11. Senni M, Tribouilloy C, Rodeheffer R, et al. Congestive heart failure in the community: A study of all incident cases in Olmsted county, Minnesota, in 1991. Circulation 1998; 98:2282-2289.
12. Cohen-Solal A, Desnos M, Delahaye F, et al. A national survey of heart failure in French hospitals. Eur Heart J 2000; 21:763-769.
13. Abraham WT, Young JB, León AR, et al. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter defibrillator, and mildly symptomatic chronic heart failure. Circulation 2004; 110:2864-2868.
14. Mortensen PT, Søgaard P, Mansour H, et al. Sequential biventricular pacing: Evaluation of safety and efficacy. Pacing Clin Electrophysiol 2004; 27:339-345.
15. Ehrlich JR, Nattel S, Hohnloser SH. Atrial fibrillation and congestive heart failure: Specific considerations at the intersection of two common and important cardiac disease sets. J Cardiovasc Electrophysiol 2002; 13:399-405.
16. Di Lenarda A, Scherillo M, Maggioni AP, et al. Current presentation and management of heart failure in cardiology and internal medicine hospital units: A tale of two worlds-the TEMISTOCLE study. Am Heart J 2003; 146:E12.
17. Maggioni AP, Sinagra G, Opasich C, et al. Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: The BRING-UP experience. Heart 2003; 89:299-305.
18. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999; 353:2001-2007.
19. Adams KF, Dunlap SH, Sueta CA, et al. Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol 1996; 28:1781-1788.
20. Likoff MJ, Chandler SL, Kay HR. Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol 1997; 59:634-638.
21. Cohn J, Aichibald DG, Ziesche S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. N Engl J Med 1986; 314:1547-1552.
22. Packer M, Carver R, Rodeheffer Jr, et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 1991; 325:1468-1475.
23. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 1995; 273:1450-1456.
24. Gasparini M, Mantica M, Galimberti P, et al. Is the outcome of cardiac resynchronization therapy related to the underlying etiology? Pacing Clin Electrophysiol 2003; 26(Pt. II):175-180.
25. Molhoek SG, Bax JJ, Van Erven L, et al. Comparison of benefits from cardiac resynchronization therapy in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathy. Am J Cardiol 2004; 93:860-863.
26. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346:877-883.
27. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352:3225-3239.
28. Reuter S, Garrigue S, Barold SS, et al. Comparison of characteristics in responders versus nonresponders with biventricular pacing for drug-resistant congestive heart failure. Am J Cardiol 2002; 89:346-350.
29. Toussaint JF, Lavergne T, Kerrou K, et al. Basal asynchrony and resynchronization with biventricular pacing predict long-term improvement of LVfunction in heart failure patients. Pacing Clin Electrophysiol 2003; 26:1815-1823.
30. Molhoek SG, Bax JJ, Boersma E, et al. QRS duration and shortening to predict clinical response to cardiac resynchronization therapy in patients with end-stage heart failure. Pacing Clin Electrophysiol 2004; 27:308-313.
31. Gasparini M, Galimberti P, Agricola S, et al. Long-term follow-up after cardiac resynchronization therapy: Poor clinical outcome in patients enrolled in NYHA Class IV. (Abstract) Eur Heart J 2003; 24:363.
32. Gasparini M, Mantica M, Galimberti, et al. Beneficial effects of biventricular pacing in patients with a "narrow" QRS. Pacing Clin Electrophysiol 2003; 26(Pt. II):169-174.